NXTP — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
CellRep develops an AI-powered platform that discovers small molecules to reprogram exhausted immune cells, enhancing their function for therapeutic applications including cancer immunotherapy and chronic viral infections.
AI & Machine LearningBiotechLongevity
Alfonso Amat(CEO & Co-Founder)inFederico Perdomo Celis(CSO & Co-Founder)inManuel Franco Cortés(CCO & Co-Founder)Julian Ganzabal(CAIO & Co-Founder)in
Co-investorsAIR CapitalGRIDXRiverwood Capital
Openlayer provides a platform for testing, monitoring, and managing AI models across the development and production lifecycle.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US
Gabriel Bayomi Kalejaiye(Founder)inVikas Nair(Co-founder & CPO)inRishab Ramanathan(Co-founder & CTO)inBoard Guillermo Rauch(Founder & CEO of Vercel)Gabriel Bayomi Tinoco Kalejaiye(Founder)inGabriel Bayomi(Co-founder & CEO)
Co-investorsGaingelsGround Up VenturesKPN VenturesMantis CapitalMento vcMindset Venture+11 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Surus AI
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













__Twitter.png)


